We have undertaken this line of inquiry to (i) explore possible mechanistic similarities or differences to pharmacologic NF‐κB inhibition (ii) support potential pre‐clinical explorations of curcumin in preventing the oncogenic bile reflux effect. This evidence concerns the gene NFKB1 and bile reflux.